Kantoff Philip W. 4
4 · Context Therapeutics Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Kantoff Philip W.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-02+25,000→ 25,000 totalExercise: $2.19Exp: 2032-06-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer.